PulseAugur
LIVE 14:14:30
commentary · [2 sources] · · 中文(ZH) 南京医药：拟出资不超4.5亿元设立并购基金专项收购大清生物及科健科技股权
0
commentary

BYD denies Maserati acquisition rumors, cites European asset exploration

By PulseAugur Editorial · Summary by gemini-2.5-flash-lite from 2 sources

BYD has officially denied rumors of considering an acquisition of Maserati. The company's executive vice president had previously mentioned exploring high-end European assets, including Maserati, and engaging in discussions with Stellantis Group about acquiring idle production facilities in Europe. BYD clarified that while they are evaluating potential acquisitions or investments in European luxury brands, there is no current plan to purchase Maserati. AI

Summary written by gemini-2.5-flash-lite from 2 sources. How we write summaries →

RANK_REASON The cluster discusses rumors and official denials regarding a potential acquisition, which falls under commentary rather than a concrete event.

Read on 36氪 (36Kr) →

COVERAGE [2]

  1. 36氪 (36Kr) TIER_1 中文(ZH) ·

    Nanjing Pharma: Plans to Invest No More Than 450 Million Yuan to Set Up M&A Fund to Specially Acquire Shares in Daqing Bio and Kejian Technology

    36氪获悉，南京医药公告，公司拟出资不超过4.5亿元，与新工产投、新工医疗并购基金共同投资设立大清并购基金。该基金成立后将专项用于并购大清生物44.95%股权和科健科技50.98%股权，并购总金额为7.47亿元。交易完成后，大清并购基金、大清生物、科健科技将纳入公司合并报表范围。

  2. 36氪 (36Kr) TIER_1 中文(ZH) ·

    BYD denies rumors of acquiring Maserati

    针对网络上“比亚迪正在考虑收购玛莎拉蒂”的传言，比亚迪官方回复表示，不属实，谣言。据悉，近日，比亚迪执行副总裁李柯，在伦敦的一场行业会议上表示，公司“确实在看欧洲市场的高端资产，包括玛莎拉蒂在内”。同时，比亚迪方面正式回复，公司正在与Stellantis集团进行洽谈，确认有意收购后者在欧洲的闲置产能工厂，并正在评估收购或投资玛莎拉蒂等欧洲高端品牌的可能性。（凤凰网科技）

RELATED ENTITIES

RELATED TOPICS